meglitinide has been researched along with biguanides in 21 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 17 (80.95) | 29.6817 |
2010's | 4 (19.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirsch, IB; White, JA | 1 |
Feinglos, MN; Luna, B | 1 |
McCormick, M; Quinn, L | 1 |
Inzucchi, SE; Mayerson, AB | 1 |
Slocum, JM; Sosa, ME | 1 |
Muller, AA | 1 |
Adler, Y; Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
Bell, DS | 1 |
Purnell, JQ; Weyer, C | 1 |
Car, J; Majeed, A; Patel, H; Srishanmuganathan, J | 1 |
Ratner, RE; Uwaifo, GI | 1 |
Levetan, C | 1 |
Scemons, D | 1 |
Modi, P | 1 |
Hermansen, K; Mortensen, LS | 1 |
Avery, MA; Chittiboyina, AG; Kurtz, TW; Mizuno, CS; Pershadsingh, HA | 1 |
Fisman, EZ; Motro, M; Tenenbaum, A | 1 |
Kopecky, C | 1 |
Kashyap, SR; Kattan, MW; Raghavan, D; Sun, GE; Wells, BJ; Yip, K; Zimmerman, R | 1 |
Abe, J; Hara, H; Kinosada, Y; Nagasawa, H; Nakamura, M; Nishibata, Y; Suzuki, Y; Umetsu, R | 1 |
Bailey, CJ; Barnett, AH; Tahrani, AA | 1 |
18 review(s) available for meglitinide and biguanides
Article | Year |
---|---|
Nonhypoglycemic drug reactions of agents used to treat diabetes.
Topics: Benzamides; Biguanides; Diabetes Mellitus; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles | 2000 |
Oral agents in the management of type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2001 |
Treatment of type 2 diabetes mellitus: pharmacologic intervention.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Type 2 diabetes therapy. A pathophysiologically based approach.
Topics: alpha-Glucosidases; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazoles; Thiazolidinediones | 2002 |
Use of antidiabetes agents in pregnancy: current practice and controversy.
Topics: Administration, Oral; Benzamides; Biguanides; Diabetes, Gestational; Enzyme Inhibitors; Female; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Polycystic Ovary Syndrome; Pregnancy; Pregnancy in Diabetics; Sulfonylurea Compounds; Thiazoles | 2002 |
Managing pediatric ingestions of the new antidiabetic agents.
Topics: Benzamides; Biguanides; Child, Preschool; Emergency Medical Services; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Male; Poisoning; Rosiglitazone; Thiazolidinediones | 2004 |
Oral antidiabetic therapy in patients with heart disease. A cardiologic standpoint.
Topics: Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Drug Combinations; Glycoside Hydrolase Inhibitors; Heart; Heart Diseases; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones; Treatment Outcome | 2004 |
A comparison of agents used to manage type 2 diabetes mellitus: need for reappraisal of traditional approaches.
Topics: Animals; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Inflammation; Insulin; Insulin Resistance; Insulin Secretion; Sulfonylurea Compounds; Thiazolidinediones | 2004 |
Weight effect of current and experimental drugs for diabetes mellitus: from promotion to alleviation of obesity.
Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Glucagon; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Islet Amyloid Polypeptide; Obesity; Peptide Fragments; Protein Precursors; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain | 2003 |
Differential effects of oral hypoglycemic agents on glucose control and cardiovascular risk.
Topics: Administration, Oral; Benzamides; Biguanides; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Risk Factors; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
Oral antidiabetic agents in type 2 diabetes.
Topics: Adenosine Deaminase Inhibitors; Administration, Oral; Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide-1 Receptor; Glycoproteins; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Receptors, Glucagon; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
Are you up-to-date on diabetes medications?
Topics: Amyloid; Benzamides; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Monitoring; Exenatide; Glycated Hemoglobin; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Islet Amyloid Polypeptide; Patient Selection; Peptides; Sulfonylurea Compounds; Thiazolidinediones; Venoms | 2007 |
Diabetes beyond insulin: review of new drugs for treatment of diabetes mellitus.
Topics: Administration, Inhalation; Benzamides; Benzoates; Biguanides; Blood Glucose; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidases and Tripeptidyl-Peptidases; Drug Therapy, Combination; Glucosidases; Humans; Hypoglycemic Agents; Insulin; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
Bodyweight changes associated with antihyperglycaemic agents in type 2 diabetes mellitus.
Topics: Amyloid; Benzamides; Biguanides; Body Weight; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Glucagon-Like Peptide 1; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Insulin Secretion; Islet Amyloid Polypeptide; Obesity; Sulfonylurea Compounds; Thiazolidinediones; Weight Gain | 2007 |
Type 2 diabetes and oral antihyperglycemic drugs.
Topics: Administration, Oral; Animals; Benzamides; Biguanides; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Humans; Hypoglycemic Agents; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Non-insulin antidiabetic therapy in cardiac patients: current problems and future prospects.
Topics: Benzamides; Biguanides; Coronary Disease; Diabetic Angiopathies; Drug Therapy, Combination; Humans; Hypoglycemic Agents; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2008 |
Use of noninsulin antidiabetic medications in hospitalized patients.
Topics: Benzamides; Biguanides; Bromocriptine; Diabetes Mellitus; Dipeptidyl-Peptidase IV Inhibitors; Glycoside Hydrolase Inhibitors; Hospitalization; Humans; Hypoglycemia; Hypoglycemic Agents; Incretins; Islet Amyloid Polypeptide; Metformin; Sulfonylurea Compounds; Thiazolidinediones | 2013 |
Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Dipeptidyl-Peptidase IV Inhibitors; Drug Therapy, Combination; Glucagon-Like Peptide-1 Receptor; Glycoside Hydrolase Inhibitors; Humans; Hypoglycemic Agents; Insulin; Sodium-Glucose Transporter 2 Inhibitors; Sulfonylurea Compounds; Thiazolidinediones | 2016 |
3 other study(ies) available for meglitinide and biguanides
Article | Year |
---|---|
Trends in the prescription and cost of diabetic medications and monitoring equipment in England 1991-2004.
Topics: Administration, Oral; Benzamides; Biguanides; Blood Glucose Self-Monitoring; Diabetes Mellitus; Drug Costs; Drug Utilization; England; Equipment and Supplies; Family Practice; Health Care Costs; Humans; Hypoglycemic Agents; Insulin; Pharmacies; Sulfonylurea Compounds; Thiazolidinediones | 2007 |
Gender-specific effects of oral hypoglycaemic agents on cancer risk in type 2 diabetes mellitus.
Topics: Benzamides; Biguanides; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; Incidence; Male; Middle Aged; Neoplasms; Odds Ratio; Ohio; Proportional Hazards Models; Registries; Retrospective Studies; Risk; Sex Factors; Sulfonylurea Compounds; Thiazolidinediones | 2014 |
[Evaluation of the association between the use of oral anti-hyperglycemic agents and hypoglycemia in Japan by data mining of the Japanese Adverse Drug Event Report (JADER) database].
Topics: Acarbose; Administration, Oral; Adverse Drug Reaction Reporting Systems; Benzamides; Biguanides; Data Mining; Databases, Pharmaceutical; Diabetes Mellitus, Type 2; Humans; Hypoglycemia; Hypoglycemic Agents; Japan; Pyrazines; Risk; Sitagliptin Phosphate; Sulfonylurea Compounds; Thiazolidinediones; Triazoles | 2014 |